Target intelligence / Profile preview

RING1 and YY1-binding protein (RYBP)

Target
RYBP
Molecular classification
Other (Polycomb group protein), Ubiquitin-binding protein, Protein complex subunit, Chromatin-modifying protein
01

Overview

RING1 and YY1-binding protein (RYBP) is a multifunctional nuclear protein that acts as a component and regulator of the Polycomb repressive complex 1 (PRC1). RYBP interacts directly with RING1A, RING1B, and transcription factor YY1, as well as the PcG protein M33, serving both as a structural element and an enzymatic stimulator within PRC1 complexes. It contains an N-terminal C2C2 zinc finger motif and is highly conserved with YAF2, another Polycomb group protein and YY1 interactor. RYBP's inclusion in PRC1 complexes increases the E3 ligase activity for histone H2A lysine 119 monoubiquitination (H2AK119ub1), thereby enhancing gene repression and contributing to the maintenance of chromatin structure. Loss or dysregulation of RYBP alters histone modification patterns and gene expression, resulting in chromatin domain erosion and has been implicated in cancer and potentially other developmental or neurodevelopmental disorders. RYBP also has known roles in apoptosis through interactions with death effector domain proteins and apoptin. It is not a direct receptor, enzyme, transporter, or ion channel, but rather a chromatin-associated regulatory protein that may serve as a therapeutic target in contexts where PRC1 function is aberrant. No approved drugs specifically target RYBP; rather, drug development efforts in chromatin biology and Polycomb complexes may indirectly affect its activity.

Other names
DEDAFYEAF1APAP-1AAP1Apoptin-associating protein 1Death effector domain-associated factorYY1 and E4TF1-associated factor 1ring1 interactor RYBP
02

Mechanism of action

Modulation of Polycomb repressive complex 1 (PRC1) function; Stimulation of histone H2A ubiquitination (H2AK119ub1) via PRC1

03

Biological functions

Gene repressionChromatin modificationProtein–protein interactionRegulation of histone modificationRegulation of apoptosis
04

Disease associations

CancerOther (Developmental disorders, possibly neurodevelopmental disorders based on chromatin biology)

Beyond the preview

Go deeper on RING1 and YY1-binding protein (RYBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RING1 and YY1-binding protein (RYBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call